Acceder

Farmas USA

135K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
5.846 / 16.989
#46761

Re: Farmas USA

Amiga Zoka me estaña Chile gano 2 a cero Viva Chile

#46763

Re: Farmas USA.

DNDN: 3 Terrific Reasons To Buy Dendreon http://m.seekingalpha.com/article/2275723?source=ansh

--------
Para los gallegos de este foro, favor sacar ticket visitar y traernos informacion
--
Biospain 2014
Santiago de Compostela, Spain
September 24-26
BIOSPAIN 2014 is Europe's largest biotech event organized entirely by a national bioindustry association and one of the largest in the world by the number of one-to-one meetings (2.775) and participating companies (762).

BIOSPAIN is organized by ASEBIO, the Spanish Bioindustry Association and co-organized in this edition together with the Government of the Autonomous Region of Galicia.

Once again in the 2014 edition, delegates will take advantage of the best partnering solution to organize their one-to-one meetings, partneringONE by EBD Group.

Apart from executives from the biotech and pharmaceutical industry, the event is also a meeting place for industry leaders from the diagnostics industry, digital health companies, investors, academic and research institutions and others. BIOSPAIN is not only the perfect place to discover the fast growing biotech industry in the South of Europe but also the platform to explore other high growth geographical areas such as Latin America and the rest of Westerm Europe.

There is still some exhibition space left to book your booth and time slots available to present your company at the investment forum. Don't miss this great opportunity by registering now!

To get an updated list of companies attending, exhibitors, investors & speakers, please visit www.biospain2014.org or call us at +34 912 109 374

David Fernández
[email protected]

Esther Campos
[email protected] We look forward to welcoming you next September in Santiago de Compostela!
http://biospain2014.org/

#46766

Re: Farmas USA

Forbes "Mutations That Prevent Heart Attacks Upend The Search For New Drugs"


Studies identify mutations in APOC3 gene as target for heart disease therapies 
 
Gene mutation associated with lower risk of heart disease

Y que relacion tiene esto con Amarin?

Pues esta, del 2 de Mayo 2014
 
Amarin Announces Presentation of New MARINE and ANCHOR Post-Hoc Analyses at National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels

 
AMRN

 

#46767

Re: Farmas USA

AMRN

Pero no dijo la fda que no tenía demostrados efectos cardiovasculares? ;-)

Brokers destacados